Takeda Pharmaceutical (Germany) Today
| TKD Stock | EUR 25.30 0.10 0.40% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Takeda Pharmaceutical is trading at 25.30 as of the 30th of November 2024. This is a 0.40 percent increase since the beginning of the trading day. The stock's lowest day price was 25.3. Takeda Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Takeda Pharmaceutical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Takeda Pharmaceutical Company Limited, together with its subsidiaries, engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. The company has 1.56 B outstanding shares. More on Takeda Pharmaceutical
Moving together with Takeda Stock
Moving against Takeda Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Takeda Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Takeda Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Takeda Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Takeda Pharmaceutical (TKD) is traded on Frankfurt Exchange in Germany and employs 47,347 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 44.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Takeda Pharmaceutical's market, we take the total number of its shares issued and multiply it by Takeda Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Takeda Pharmaceutical classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 1.56 B outstanding shares.
Takeda Pharmaceutical has accumulated about 3.41 B in cash with 1.12 T of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.36.
Check Takeda Pharmaceutical Probability Of Bankruptcy
Ownership AllocationTakeda Pharmaceutical shows a total of 1.56 Billion outstanding shares. 30% of Takeda Pharmaceutical outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Takeda Ownership Details
Takeda Pharmaceutical Risk Profiles
Although Takeda Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Takeda Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8674 | |||
| Standard Deviation | 1.11 | |||
| Variance | 1.24 | |||
| Risk Adjusted Performance | (0.06) |
Takeda Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Takeda Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Takeda Pharmaceutical Corporate Management
Elected by the shareholders, the Takeda Pharmaceutical's board of directors comprises two types of representatives: Takeda Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Takeda. The board's role is to monitor Takeda Pharmaceutical's management team and ensure that shareholders' interests are well served. Takeda Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Takeda Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christophe Weber | CEO Pres | Profile | |
| Christopher OReilly | Global Fin | Profile | |
| Andrew Plump | Pres Director | Profile | |
| Seigo Izumo | Chair Board | Profile | |
| Gabriele Ricci | Chief Officer | Profile | |
| Salvatore Alesci | Member Policy | Profile | |
| Iwaaki Taniguchi | Sr Department | Profile |
Other Information on Investing in Takeda Stock
Takeda Pharmaceutical financial ratios help investors to determine whether Takeda Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takeda with respect to the benefits of owning Takeda Pharmaceutical security.